June 15, 2015

Online registration deadline is June 26th! Register and access meeting information on the NRG Oncology website.

MEETING HIGHLIGHT
Interested in learning more about a trial assessing whether lifestyle intervention can enhance survival and quality of life for patients with ovarian cancer? If so, plan to attend the Protocol 225 Workshop being held on Saturday, July 18 from 10:00 am – 12:00 pm.

CLOSURES
BREAST
Clarification: NRG-BR001, Osseous (bone) metastatic site was temporarily closed to accrual on June 9; however, the other six metastatic locations including spinal/paraspinal remain open.

GYNECOLOGIC
GOG-0279: Temporarily closed to accrual June 15, 2015

AMENDMENTS AND UPDATES
BREAST
NSABP B-43: Amendment 7, version date: November 14, 2014 (posted to NSABP and CTSU websites)

NSABP B-47
: Amendment 6, version date: November 28, 2014 (posted to NSABP and CTSU websites)

GYNECOLOGIC
GOG-0213: Amendment 14, version date: May 28, 2015

HEAD & NECK
RTOG 0920: Amendment 9, version date: May 18, 2015

LUNG
NRG-LU001: Amendment 1, version date: May 7, 2015

FORMS UPDATES
RTOG 0815: The ACE 27 Form is now available on the CTSU website

OTHER PROTOCOL NOTICES
BREAST
NSABP B-51/RTOG 1304: Updated Fact Sheet (posted to NSABP and CTSU websites)

GASTROINTESTINAL Webinar
RTOG 1112 and NRG-GI001: A webinar will be held on June 18, 2015. Please visit the website for further details and to register for the webinar.

GYNECOLOGIC
GOG-0274/RTOG 1174 - Planned outage of the InForm trials system on Tuesday, June 16, 2015 from 2 a.m. to 6 a.m. (AEST). This will occur on Monday June 15, 2015 from 12 p.m. to 4 p.m. (EDT). InForm will not be available during this time.

Vision Tree Webinar
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, and NRG-HN001. Space is limited so register now and reserve your seat. The next training is scheduled for June 23, 2015.

DRUG SAFETY REPORTS and INVESTIGATOR’S BROCHURE UPDATE
Safety updates and an Investigator’s Brochure update have been issued for GOG legacy studies. For details, please see the GOG Weekly Mailing page.

Safety updates have been issued for NSABP legacy studies. For details, please see the NSABP Members’ Area or the E-mail Distributions page and the CTSU website.

NCORP
The NRG CCDR Committee is seeking nominations for new committee members. Nominations will be accepted until June 22, 2015. Please see the NRG website for further details.

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

JOURNAL ARTICLES
Coleman RL, Sill MW, Bell-McGuinn K, Aghajanian C, Gray HJ, Tewari KS, Rubin SC, Rutherford TJ, Chan JK, Chen A, Swisher EM. A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2015 Jun;137(3):386-91. doi: 10.1016/j.ygyno.2015.03.042. Epub 2015 Mar 24. PMID: 25818403. Read more

PUBLICATIONS REMINDERS
Please note the following upcoming meeting and abstract submission deadline dates.

Upcoming scientific meetings
American Association of Medical Dosimetrists (AAMD), June 21-25, 2015, Orlando, FL
American Association of Physicists in Medicine (AAPM),July 12-16, 2015, Anaheim, CA
Multinational Association of Supportive Care in Cancer (MASCC), June 25-27, 2015, Copenhagen, Denmark

Upcoming abstract submission deadline
American Society of Clinical Oncology (ASCO) Breast, September 25-27, 2015, San Francisco, CA; meeting abstract submission deadline June 16, 2015
Society for Neuro-Oncology (SNO) November 19-22, 2015, San Antonio, TX; meeting abstract submission deadline June 15, 2015

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Unsubscribe